Anika Therapeutics, Inc. (ANIK) vs Indaptus Therapeutics, Inc. (INDP)
A side-by-side comparison of Anika Therapeutics, Inc. and Indaptus Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ANIK
Anika Therapeutics, Inc.
$19.16HealthcareDelayed quote: Oct 6, 2026, 2:29 PM EDT
INDP
Indaptus Therapeutics, Inc.
$2.54HealthcareDelayed quote: Oct 6, 2026, 2:30 PM EDT
Total return — ANIK vs INDP
growth of $100 · dividends reinvested · last 10yANIK -57.8% (-8.3%/yr)INDP -100.0% (-57.2%/yr)ANIK compounded faster over this window
Log scale — wide-divergence pair
ANIK INDP
ANIK vs INDP: by the numbers
- •INDP is the larger company ($288M vs $256M market cap).
- •Both run net losses; INDP's is the smaller (0.00% vs -3.14% net margin).
Metrics side by side
Valuation
| Metric | ANIK | INDP |
|---|---|---|
| Forward P/E | 18.25 | N/A |
| P/S ratio | 2.13 | N/A |
| P/B ratio | 1.87 | 25.29 |
| EV / EBITDA | 474.07 | N/A |
| FCF yield | 0.22% | N/A |
Profitability
| Metric | ANIK | INDP |
|---|---|---|
| Gross margin | 62.16% | 0.00% |
| Operating margin | -4.24% | 0.00% |
| Net margin | -3.14% | 0.00% |
| ROE | -2.76% | -135.62% |
| ROIC | -3.17% | -129.90% |
Growth (annualized)
| Metric | ANIK | INDP |
|---|---|---|
| Revenue CAGR (5Y) | -2.48% | N/A |
| FCF CAGR (5Y) | -39.38% | N/A |
| Total return CAGR (5Y) | -13.40% | -58.32% |
Frequently asked
- How have ANIK and INDP total returns compared?
- Over the past 10 years, ANIK delivered -8.51% and INDP delivered -57.48% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.